Abed Alrazzak Kerhani

Dr. Abed Alrazzak Kerhani

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2024 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
AFAreeba Fareed
Areeba Fareed
SFSolay Farhat
Solay Farhat
AKAbed Alrazzak Kerhani
Abed Alrazzak Kerhani
ACAnood Choudhary
Anood Choudhary
SRSyeda Sadia Masood Raza
Syeda Sadia Masood Raza
An abstract is unavailable. This article is available as a PDF only.

27 May 2025
Verified
Book Chapter
Open access
PDF file
MYMohamed Yazbeck
Mohamed Yazbeck
AKAbed Alrazzak Kerhani
Abed Alrazzak Kerhani
Aqueductal stenosis is the primary cause of congenital and acquired hydrocephalus, which results from an obstruction in cerebrospinal fluid (CSF) flow through the cerebral aqueduct. The condition causes increasing intracranial pressure and progressive ventricular dilution that requires acute surgical intervention. Two of the primary treatment choices are ventriculoperitoneal (VP) shunting and endoscopic third ventriculostomy (ETV). Although VP shunting is still quite common, it has long-term side effects including shunt dependency, malfunction, and infection. By restoring CSF circulation, ETV presents a physiological substitute; yet, success rates depend on patient age, etiology, and anatomical factors. Rising approaches are ETV with choroid plexus cauterization, neuronavigation-assisted surgeries, and robotic-assisted neuroendoscopy, which is improving surgical results. Despite these advances, there nevertheless remain challenges in optimizing patient selection and minimizing postoperative complications. Emphasizing clinical decision-making and long-term management, this review offers an in-depth examination of the pathophysiology, diagnostic tools, and transforming surgical approaches for aqueductal stenosis.